中慧生物-B(02627)公布配发结果,公司全球发售3344.26万股股份,香港公开发售占11.95%,国际发售占88.05%。最终发售价每股12.9港元,全球发售净筹约3.83亿港元。每手200股,预期H股将于2025年8月11日(星期一)上午九时正(香港时间)开始在联交所买卖。
其中,香港公开发售获4007.64倍认购,国际发售获0.99倍认购。
责任编辑:卢昱君
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.